Neonatal Unit, Department of Paediatrics, CHU of Reunion Island, Northern Hospital Group, Saint-Denis, France.
Neurology Unit, Department of Paediatrics, CHU of Toulouse Purpan, Toulouse, France.
Neuropediatrics. 2020 Jun;51(3):221-224. doi: 10.1055/s-0039-3402011. Epub 2019 Dec 30.
Seventeen-day-old twins were hospitalized for neonatal herpes simplex virus 1 (HSV-1) with central nervous system disease and internal capsule and thalamic lesions on magnetic resonance imaging (MRI). They were treated with the usual intravenous (IV) treatment and oral therapy for 6 months. The clinical course was good in both children with negative HSV polymerase chain reaction on completion of IV therapy. The neurological condition recurred in one child with new radiological lesions at 7 months of age, 2 weeks after discontinuation of oral treatment. Cerebral lesions highlighted on the MRI scan are specific to the neonatal period and impact long-term prognosis. The likely genetic predisposition in this case is interesting and requires further investigation. In addition, this case raises questions about the duration of oral acyclovir suppressive therapy.
17 天大的双胞胎因单纯疱疹病毒 1(HSV-1)感染新生儿中枢神经系统疾病和磁共振成像(MRI)显示内囊和丘脑病变而住院。他们接受了常规静脉(IV)治疗和口服治疗 6 个月。在完成 IV 治疗后,两名儿童的 HSV 聚合酶链反应均为阴性,临床病程良好。在停止口服治疗 2 周后,1 名儿童 7 个月大时出现新的放射学病变,神经状况再次恶化。MRI 扫描显示的脑部病变具有特定的新生儿期特征,会影响长期预后。这种情况下可能存在的遗传易感性很有趣,需要进一步研究。此外,该病例还提出了关于口服阿昔洛韦抑制治疗持续时间的问题。